1 / 8

Cephalosporin Drugs Market To Surpass US$ 19,073.1 Million By 2026 - Coherent Market Insights

u201cCoherent Market Insights u201cCEPHALOSPORIN DRUGS MARKET u2013 GLOBAL TRENDS, ESTIMATES AND FORECASTS, 2020-2027u2033

SANJAYCMI
Download Presentation

Cephalosporin Drugs Market To Surpass US$ 19,073.1 Million By 2026 - Coherent Market Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CEPHALOSPORIN DRUGS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

  2. REPORT DESCRIPTION Cephalosporin Drugs Market - Overview Global Cephalosporin Drugs Market, by Generation (First-generation Cephalosporin, Second- generation Cephalosporin, Third-generation Cephalosporin, Fourth-generation Cephalosporin, and Fifth-generation Cephalosporin), by Type (Branded Cephalosporin Drugs and Generic Cephalosporin Drugs), by Formulation (Oral ( Tablets, Capsules, and Liquid) and Injection), by Indication (Respiratory Tract Infection, Skin Infection, Ear Infection, Bacterial Infection, Urinary Tract Infection, Sexually Transmitted Infection, Sinus Infection, Surgical Prophylaxis, and Others (Meningitis, Acute Abdomen Infection, and Pelvic Infection)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 14,240.0 million in 2018, and is projected to exhibit a CAGR of 3.8% over the forecast period (2019 - 2026), as highlighted in a new report published by. Increasing pharmacogenomics-based drug discovery, and high number of strategic partnerships for launch and distribution of cephalosporin drugs in different countries are some of the major factors driving growth of the cephalosporin drugs market. Various organizations are focused on receiving approvals from the Food and Drug Administration (FDA) for clinical trials in order to develop and launch new generation drugs for the treatment of bacterial infections. research on antibiotic resistance, support of several governments for Browse Research Reports: https://www.coherentmarketinsights.com/market- insight/cephalosporin-drugs-market-2893 © Coherent market Insights. All Rights Reserved

  3. REPORT DESCRIPTION The two studies will evaluate ceftobiprole for the treatment of Staphylococcus aureus bacteremia (bloodstream infections) and acute bacterial skin and skin structure infections. Manufacturers in the cephalosporin drugs market are focusing on strategic partnerships in order to gain significant market share. For instance, in April 2018, Basilea Pharmaceutica Ltd. announced that its partner Avir Pharma Inc. launched Basilea's hospital antibiotic Zevtera (ceftobiprole) in Canada. Furthermore, in May 2018, Basilea Pharmaceutica Ltd. announced that its partner Hikma Pharmaceuticals LLC launched Basilea's hospital antibiotic Zevtera (ceftobiprole) in Saudi Arabia. Browse 53 Market Data Tables and 50 Figures spread through 236 Pages and in-depth TOC on "Global Cephalosporin Drugs Market, By Generation (First-generation, Cephalosporin, Second- generation Cephalosporin, Third-generation Cephalosporin, Fourth-generation Cephalosporin, and Fifth-generation Cephalosporin), By Type (Branded Cephalosporin Drugs and Generic Cephalosporin Drugs), By Formulation (Oral (Tablets, Capsules, and Liquid) and Injection), By Indication (Respiratory Tract Infection, Skin Infection, Ear Infection, Bacterial Infection, Urinary Tract Infection, Sexually Transmitted Infection, Sinus Infection, Surgical Prophylaxis, and Others (Meningitis, Acute Abdomen Infection, and Pelvic infection)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026" Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/2893 © Coherent market Insights. All Rights Reserved

  4. REPORT DESCRIPTION Furthermore, increasing funding from several governments for research and development regarding antibiotic resistance is expected to contribute to growth of the cephalosporin drugs market. For instance, in September 2018, National Institutes of Health (NIH) granted US$ 9.4 million for establishing the Center for Biomedical Research Excellence (COBRE) to address the worldwide threat of drug-resistant pathogens to The Miriam Hospital in Rhode Island, U.S. Key Takeaways of the Global Cephalosporin Drugs Market: The global cephalosporin drugs market is expected to witness a CAGR of 3.8% during the forecast period (2019–2026), owing to increasing research & development activities related to cephalosporin drugs and new product launches. Among generations, the third-generation cephalosporin segment is expected to account for major revenue share in 2026. This is owing to increasing product launches in the third- generation cephalosporin drugs. For instance, in March 2017, Pfizer Inc. launched the antibiotic Zavicefta (Third-generation cephalosporin) in the U.K. and Germany for the treatment of aerobic gram-negative infections caused by resistant bacteria. Major players operating in the global cephalosporin drugs market include, Merck & Co. Inc., GlaxoSmithKline plc., Pfizer Inc., Allergan plc., Abbott Laboratories, Basilea Pharmaceutica Ltd., Sanofi S.A., F. Hoffmann-La Roche AG, Lupin Limited, Teva Pharmaceutical Industries Ltd., and B. Braun Melsungen AG Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/2893 © Coherent market Insights. All Rights Reserved

  5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

  6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

  7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

  8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved

More Related